Who owns ATEA PHARMACEUTICALS INC?
- Ticker: AVIR
- CUSIP Number: 04683r106
Tip: Access positions for across all investors
Analyze quarterly positions in Atea Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atea Pharmaceuticals stock
Who bought or sold ATEA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EcoR1 Capital | 7.0M | $21M | 0% | Dec 2023 |
|
| BML Capital Management | 5.5M | $17M | 14% | Dec 2023 |
|
| Vanguard Group | 4.6M | $14M | 1% | Dec 2023 |
|
| Tang Capital Management | 4.1M | $12M | 13% | Dec 2023 |
|
| Federated Investors | 596k | $1.8M | -2% | Dec 2023 |
|
| Charles Schwab Investment Management | 584k | $1.8M | 0% | Dec 2023 |
|
| Jacobs Levy Equity Management | 551k | $1.7M | -1% | Dec 2023 |
|
| Newtyn Management | 509k | $1.6M | 27% | Dec 2023 |
|
| Banque Pictet & Cie Sa | 345k | $1.1M | 0% | Dec 2023 |
|
| Two Sigma Advisers | 319k | $973k | 55% | Dec 2023 |
|
| CM Management | 270k | $824k | -2% | Dec 2023 |
|
| Bank of New York Mellon | 255k | $779k | -21% | Dec 2023 |
|
| Bank of America Corporation | 244k | $743k | 153% | Dec 2023 |
|
| Goldman Sachs Group | 229k | $698k | -12% | Dec 2023 |
|
| Barclays | 197k | $601k | 669% | Dec 2023 |
|
| Citadel Advisors | 190k | $579k | -69% | Dec 2023 |
|
| D. E. Shaw & Co | 185k | $565k | 165% | Dec 2023 |
|
| Hsbc Holdings | 180k | $554k | 1391% | Dec 2023 |
|
| Cubist Systematic Strategies | 178k | $544k | 28% | Dec 2023 |
|
| Auour Investments | 177k | $671k | 0% | Dec 2023 |
|
| Acuitas Investments | 171k | $615k | 39% | Dec 2023 |
|
| Two Sigma Investments | 162k | $494k | 199% | Dec 2023 |
|
| GSA Capital Partners | 150k | $457k | -46% | Dec 2023 |
|
| Rhumbline Advisers | 147k | $449k | 10% | Dec 2023 |
|
| State of Wisconsin Investment Board | 130k | $396k | 5% | Dec 2023 |
|
| Alliancebernstein | 121k | $368k | -3% | Dec 2023 |
|
| UBS Group | 108k | $328k | 89% | Dec 2023 |
|
| New York Life Investment Management | 103k | $314k | -3% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 101k | $307k | 0% | Dec 2023 |
|
| CSS | 93k | $283k | 11% | Dec 2023 |
|
| Dimensional Fund Advisors | 92k | $282k | 0% | Dec 2023 |
|
| Jane Street | 79k | $240k | 432% | Dec 2023 |
|
| Jpmorgan Chase & Co | 68k | $209k | 0% | Dec 2023 |
|
| ALPS Advisors | 58k | $178k | -5% | Dec 2023 |
|
| T. Rowe Price Associates | 55k | $169k | 31% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 52k | $159k | -43% | Dec 2023 |
|
| Shay Capital | 50k | $153k | 3% | Dec 2023 |
|
| MetLife Investment Advisors | 47k | $144k | 0% | Dec 2023 |
|
| Marquette Asset Management | 47k | $144k | 90% | Dec 2023 |
|
| SG Americas Securities | 43k | $130k | 23% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 39k | $117k | -5% | Dec 2023 |
|
| American International | 38k | $116k | 0% | Dec 2023 |
|
| Algert Coldiron Investors | 37k | $113k | -27% | Dec 2023 |
|
| Norges Bank Investment Management | 36k | $110k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 30k | $91k | 111% | Dec 2023 |
|
| Principal Financial Group | 28k | $84k | -10% | Dec 2023 |
|
| Brevan Howard Capital Management | 26k | $78k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 24k | $73k | 24% | Dec 2023 |
|
| Florida State Board of Administration | 22k | $67k | 0% | Dec 2023 |
|
| Ohio Pers | 18k | $55k | 0% | Dec 2023 |
|
| New York State Common Retirement Fund | 16k | $50k | -1% | Dec 2023 |
|
| Millennium Management | 16k | $48k | -64% | Dec 2023 |
|
| Wolverine Trading | 14k | $42k | 100% | Dec 2023 |
|
| Simplex Trading | 14k | $41k | 513% | Dec 2023 |
|
| Point72 Middle East FZE | 13k | $40k | 496% | Dec 2023 |
|
| Rpo | 13k | $40k | 100% | Dec 2023 |
|
| Citigroup | 13k | $38k | 1062% | Dec 2023 |
|
| Sunpointe | 12k | $48k | 0% | Mar 2024 |
|
| Graham Capital Management | 11k | $35k | 100% | Dec 2023 |
|
| China Universal Asset Management | 9.7k | $29k | 351% | Dec 2023 |
|
| Ronald Blue Trust | 8.7k | $26k | 0% | Dec 2023 |
|
| Summit Investment Advisors | 7.5k | $23k | 48% | Dec 2023 |
|
| Advisor Group Holdings | 7.3k | $22k | -20% | Dec 2023 |
|
| Amalgamated Bank | 6.8k | $21k | -11% | Dec 2023 |
|
| Legal & General Group | 6.0k | $18k | 0% | Dec 2023 |
|
| Russell Investments | 4.9k | $15k | 5% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 2.2k | $6.7k | -52% | Dec 2023 |
|
| Capital Advisors | 1.6k | $7.0k | 100% | Mar 2024 |
|
| Daiwa Securities Group | 242.00 | $999.992400 | 0% | Dec 2023 |
|
| Farther Finance Advisors | 216.00 | $658.994400 | 57% | Dec 2023 |
|
| O'Dell Group | 200.00 | $610.000000 | 100% | Dec 2023 |
|
| Frazier Financial Advisors | 120.00 | $366.000000 | 100% | Dec 2023 |
|
| Pnc Financial Services | 74.00 | $226.003400 | 100% | Dec 2023 |
|
| LM Advisors | 50.00 | $153.000000 | 100% | Dec 2023 |
|
| NISA Investment Advisors | 23.00 | $70.000500 | -100% | Dec 2023 |
|
| GPS Wealth Strategies Group | 13.00 | $39.999700 | 0% | Dec 2023 |
|
Who sold out of Atea Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vontobel Holding | Sep 2023 | 601k | $1.8M |
| Hrt Financial | Sep 2023 | 71k | $213k |
| Squarepoint Ops | Sep 2023 | 41k | $124k |
| AQR Capital Management | Sep 2023 | 30k | $91k |
| Mirae Asset Global Investments | Sep 2023 | 30k | $90k |
| Virtus ETF Advisers | Sep 2023 | 24k | $73k |
| Denali Advisors | Sep 2023 | 18k | $54k |
| Pinnacle Wealth Planning Services | Sep 2023 | 16k | $49k |
| William Blair $ Company | Sep 2023 | 10k | $31k |
| Gladius Capital Management | Sep 2023 | 8.6k | $26k |
| Cutler | Sep 2023 | 2.4k | $7.0k |
| Lazard Asset Management | Sep 2023 | 2.3k | $6.0k |
| SCBT Financial Corporation | Sep 2023 | 565.00 | $1.7k |
| Costello Asset Management | Sep 2023 | 100.00 | $300.000000 |
| Quent Capital | Sep 2023 | 35.00 | $105.000000 |